Modeling the competition between lung metastases and the immune system using agents

Marzio Pennisi, Francesco Pappalardo, Ariannna Palladini, Giordano Nicoletti, Patrizia Nanni, Pier Luigi Lollini, Santo Motta

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an effective treatment also for the cure of metastases. A future human application of the Triplex vaccine should take into account several aspects of biological behavior of the involved entities to improve the efficacy of therapeutic treatment and to try to predict, for example, the outcomes of longer experiments in order to move faster towards clinical phase I trials. To help to address this problem, MetastaSim, a hybrid Agent Based - ODE model for the simulation of the vaccine-elicited immune system response against lung metastases in mice is presented. The model is used as in silico wet-lab. As a first application MetastaSim is used to find protocols capable of maximizing the total number of prevented metastases, minimizing the number of vaccine administrations.Results: The model shows that it is possible to obtain "in silico" a 45% reduction in the number of vaccinations. The analysis of the results further suggests that any optimal protocol for preventing lung metastases formation should be composed by an initial massive vaccine dosage followed by few vaccine recalls.Conclusions: Such a reduction may represent an important result from the point of view of translational medicine to humans, since a downsizing of the number of vaccinations is usually advisable in order to minimize undesirable effects. The suggested vaccination strategy also represents a notable outcome. Even if this strategy is commonly used for many infectious diseases such as tetanus and hepatitis-B, it can be in fact considered as a relevant result in the field of cancer-vaccines immunotherapy. These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model.

Original languageEnglish
Article numberS13
JournalBMC Bioinformatics
Volume11
Issue numberSUPPL. 7
DOIs
Publication statusPublished - Oct 15 2010

Fingerprint

Metastasis
Vaccines
Immune system
Vaccine
Immune System
Lung
metastasis
immune system
lungs
vaccines
Neoplasm Metastasis
Modeling
Vaccination
Cancer Vaccines
Computer Simulation
vaccination
Cancer
Clinical Trials, Phase I
Translational Medical Research
Phase I Trial

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Computer Science Applications
  • Structural Biology
  • Applied Mathematics
  • Agricultural and Biological Sciences (miscellaneous)
  • Artificial Intelligence
  • Computational Theory and Mathematics
  • Software

Cite this

Pennisi, M., Pappalardo, F., Palladini, A., Nicoletti, G., Nanni, P., Lollini, P. L., & Motta, S. (2010). Modeling the competition between lung metastases and the immune system using agents. BMC Bioinformatics, 11(SUPPL. 7), [S13]. https://doi.org/10.1186/1471-2105-11-S7-S13

Modeling the competition between lung metastases and the immune system using agents. / Pennisi, Marzio; Pappalardo, Francesco; Palladini, Ariannna; Nicoletti, Giordano; Nanni, Patrizia; Lollini, Pier Luigi; Motta, Santo.

In: BMC Bioinformatics, Vol. 11, No. SUPPL. 7, S13, 15.10.2010.

Research output: Contribution to journalArticle

Pennisi, M, Pappalardo, F, Palladini, A, Nicoletti, G, Nanni, P, Lollini, PL & Motta, S 2010, 'Modeling the competition between lung metastases and the immune system using agents', BMC Bioinformatics, vol. 11, no. SUPPL. 7, S13. https://doi.org/10.1186/1471-2105-11-S7-S13
Pennisi, Marzio ; Pappalardo, Francesco ; Palladini, Ariannna ; Nicoletti, Giordano ; Nanni, Patrizia ; Lollini, Pier Luigi ; Motta, Santo. / Modeling the competition between lung metastases and the immune system using agents. In: BMC Bioinformatics. 2010 ; Vol. 11, No. SUPPL. 7.
@article{fd4afaf8bbe74b0cb9075134272ab780,
title = "Modeling the competition between lung metastases and the immune system using agents",
abstract = "Background: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an effective treatment also for the cure of metastases. A future human application of the Triplex vaccine should take into account several aspects of biological behavior of the involved entities to improve the efficacy of therapeutic treatment and to try to predict, for example, the outcomes of longer experiments in order to move faster towards clinical phase I trials. To help to address this problem, MetastaSim, a hybrid Agent Based - ODE model for the simulation of the vaccine-elicited immune system response against lung metastases in mice is presented. The model is used as in silico wet-lab. As a first application MetastaSim is used to find protocols capable of maximizing the total number of prevented metastases, minimizing the number of vaccine administrations.Results: The model shows that it is possible to obtain {"}in silico{"} a 45{\%} reduction in the number of vaccinations. The analysis of the results further suggests that any optimal protocol for preventing lung metastases formation should be composed by an initial massive vaccine dosage followed by few vaccine recalls.Conclusions: Such a reduction may represent an important result from the point of view of translational medicine to humans, since a downsizing of the number of vaccinations is usually advisable in order to minimize undesirable effects. The suggested vaccination strategy also represents a notable outcome. Even if this strategy is commonly used for many infectious diseases such as tetanus and hepatitis-B, it can be in fact considered as a relevant result in the field of cancer-vaccines immunotherapy. These results can be then used and verified in future {"}in vivo{"} experiments, and their outcome can be used to further improve and refine the model.",
author = "Marzio Pennisi and Francesco Pappalardo and Ariannna Palladini and Giordano Nicoletti and Patrizia Nanni and Lollini, {Pier Luigi} and Santo Motta",
year = "2010",
month = "10",
day = "15",
doi = "10.1186/1471-2105-11-S7-S13",
language = "English",
volume = "11",
journal = "BMC Bioinformatics",
issn = "1471-2105",
publisher = "BioMed Central Ltd.",
number = "SUPPL. 7",

}

TY - JOUR

T1 - Modeling the competition between lung metastases and the immune system using agents

AU - Pennisi, Marzio

AU - Pappalardo, Francesco

AU - Palladini, Ariannna

AU - Nicoletti, Giordano

AU - Nanni, Patrizia

AU - Lollini, Pier Luigi

AU - Motta, Santo

PY - 2010/10/15

Y1 - 2010/10/15

N2 - Background: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an effective treatment also for the cure of metastases. A future human application of the Triplex vaccine should take into account several aspects of biological behavior of the involved entities to improve the efficacy of therapeutic treatment and to try to predict, for example, the outcomes of longer experiments in order to move faster towards clinical phase I trials. To help to address this problem, MetastaSim, a hybrid Agent Based - ODE model for the simulation of the vaccine-elicited immune system response against lung metastases in mice is presented. The model is used as in silico wet-lab. As a first application MetastaSim is used to find protocols capable of maximizing the total number of prevented metastases, minimizing the number of vaccine administrations.Results: The model shows that it is possible to obtain "in silico" a 45% reduction in the number of vaccinations. The analysis of the results further suggests that any optimal protocol for preventing lung metastases formation should be composed by an initial massive vaccine dosage followed by few vaccine recalls.Conclusions: Such a reduction may represent an important result from the point of view of translational medicine to humans, since a downsizing of the number of vaccinations is usually advisable in order to minimize undesirable effects. The suggested vaccination strategy also represents a notable outcome. Even if this strategy is commonly used for many infectious diseases such as tetanus and hepatitis-B, it can be in fact considered as a relevant result in the field of cancer-vaccines immunotherapy. These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model.

AB - Background: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an effective treatment also for the cure of metastases. A future human application of the Triplex vaccine should take into account several aspects of biological behavior of the involved entities to improve the efficacy of therapeutic treatment and to try to predict, for example, the outcomes of longer experiments in order to move faster towards clinical phase I trials. To help to address this problem, MetastaSim, a hybrid Agent Based - ODE model for the simulation of the vaccine-elicited immune system response against lung metastases in mice is presented. The model is used as in silico wet-lab. As a first application MetastaSim is used to find protocols capable of maximizing the total number of prevented metastases, minimizing the number of vaccine administrations.Results: The model shows that it is possible to obtain "in silico" a 45% reduction in the number of vaccinations. The analysis of the results further suggests that any optimal protocol for preventing lung metastases formation should be composed by an initial massive vaccine dosage followed by few vaccine recalls.Conclusions: Such a reduction may represent an important result from the point of view of translational medicine to humans, since a downsizing of the number of vaccinations is usually advisable in order to minimize undesirable effects. The suggested vaccination strategy also represents a notable outcome. Even if this strategy is commonly used for many infectious diseases such as tetanus and hepatitis-B, it can be in fact considered as a relevant result in the field of cancer-vaccines immunotherapy. These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model.

UR - http://www.scopus.com/inward/record.url?scp=77957924286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957924286&partnerID=8YFLogxK

U2 - 10.1186/1471-2105-11-S7-S13

DO - 10.1186/1471-2105-11-S7-S13

M3 - Article

C2 - 21106120

AN - SCOPUS:77957924286

VL - 11

JO - BMC Bioinformatics

JF - BMC Bioinformatics

SN - 1471-2105

IS - SUPPL. 7

M1 - S13

ER -